4TEEN4 Pharmaceuticals
Germany - HennigsdorfDiagnostics
Focus: 4TEEN4 Pharmaceuticals is a Germany-based diagnostic and therapeutic company focused on dpp3 biomarkers for organ dysfunction, with a clinical-stage pipeline centered on cardiogenic shock treatment. The company operates as a specialized player in the diagnostics-to-therapeutics space with minimal public scale data.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About 4TEEN4 Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow 4TEEN4 Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
procizumab
Cardiogenic ShockClinical Trials (2)
NCT06832722Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care
Phase 1/2Help build intelligence for 4TEEN4 Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.